Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apyx Medical Corporation - Common Stock (NQ:APYX)

3.230 +0.120 (+3.86%)
Streaming Delayed Price Updated: 10:06 AM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
From Apyx Medical Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
APYX Stock Earnings: Apyx Medical Misses EPS, Beats Revenue for Q1 2024 ↗
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Apyx Medical Corporation Announces Board Leadership Transition
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
From Apyx Medical Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Crude Oil Moves Lower; Accenture Shares Tumble After Q2 Results ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.77% to 39,814.95 while the NASDAQ rose 0.25% to 16,410.54. The... 
Via Benzinga
Topics Stocks
News headline image
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Gold Gains 1%; Micron Posts Upbeat Results ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.84% to 39,844.27 while the NASDAQ rose 0.61% to 16,469.28. The S&P... 
Via Benzinga
Topics Stocks
News headline image
APYX Stock Earnings: Apyx Medical Misses EPS, Misses Revenue for Q4 2023 ↗
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
News headline image
Earnings Scheduled For March 21, 2024 ↗
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
News headline image
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
From Apyx Medical Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
From Apyx Medical Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
From Apyx Medical Corporation
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Insiders Buying Apyx Medical And 3 Other Stocks Under $3 ↗
The Dow Jones closed higher by over 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November
From Apyx Medical Corporation
Via Business Wire
News headline image
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023
From Apyx Medical Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.